| Item Number | Description | Schedule Fee |
|---|---|---|
| 61614 | Whole body FDG PET study, following initial therapy, performed for the evaluation of suspected residual, metastatic or recurrent cancer in a patient who is undergoing, or is suitable for, active therapy, if the cancer is a typically FGD-avid cancer (R) |
$953.00 |
| Total: | $953.00 | |